Pheo Para Alliance Recognizes UCLA as Center of Excellence for Rare Endocrine Illness.
Pheo Para Alliance, a patient advocacy organization dedicated to supporting those with pheochromocytoma (pheo) and paraganglioma (para), a rare neuroendocrine tumor, has designated the UCLA Endocrine Center as a Center of Excellence, the first designation made on the west coast. The Center of Excellence Program recognizes institutions worldwide for providing cutting-edge, quality, multi-disciplinary care and participating in pheo and para and related research. UCLA’s announcement brings the total list of Clinical Centers and Centers of Excellence to seven, with more announcements slated throughout 2021. Full press release >
The maintenance of steady and predictable thyroid hormone levels in the blood is essential to health. What is the best way to take thyroid hormone? >
UCLA endocrine surgeon James Wu, MD, presented a live-streaming webinar to discuss active surveillance of low-risk tumors.
UCLA endocrine surgeons Masha Livhits, MD & Michael Yeh, MD, presented a live-streaming webinar to discuss an overview of molecular approaches to diagnosing thyroid cancer. More Webinars >
Appointment Reminders by Text - Skip the phone calls and receive your appointment reminders by text >
A new technique called Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) has been developed. With this surgery, the thyroid gland is removed without leaving any visible scars in the neck. Scarless Thyroid and Parathyroid Surgery >
Dr. Kyle Zanocco is seeing new patients in our Santa Monica location.
“All these years I just thought I had high blood pressure.” —Gloria
Gloria’s story > | More Patient Stories >
Visit us on 
